ALGS vs MDT · rev $3.6M vs P/E 21, rev $36.36B
Aligos Therapeutics Inc (ALGS) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ALGS currently screens at market cap $44.1M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ALGS and MDT stock pages for the full models.
Not investment advice.